SCHEMBL19960313

SCHEMBL19960313

S=P(c1ccc2ccccc2c1)(c1ccc2ccccc2c1)c1ccc2c(c1)nc1c3c4ccccc4ccc3c3ccc(P(=S)(c4ccccc4)c4ccc5ccccc5c4)cc3n21

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960309 1.00 KDM4E (0.30) KDM4ELMNATP53POLBMAPT
SCHEMBL19960311 1.00 KDM4E (0.30) KDM4ELMNATP53POLBMAPT
SCHEMBL19960306 0.97 KDM4E (0.32) KDM4ELMNATP53POLBMAPT
SCHEMBL19960312 0.95
SCHEMBL19960317 0.95
SCHEMBL19965996 0.95 KDM4E (0.33) KDM4EMAPT
SCHEMBL19960308 0.94
SCHEMBL19960248 0.93 KDM4E (0.30) KDM4ELMNATP53POLBMAPT
SCHEMBL19960318 0.91 KDM4E (0.34) KDM4EMAPT
SCHEMBL19965922 0.91 KDM4E (0.34) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885TP53 3534/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885TP53 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.